Severe sepsis--a new treatment with both anticoagulant and antiinflammatory properties.
M A
MA
Matthay
D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D018746:Systemic Inflammatory Response Syndrome / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology
D000893:Anti-Inflammatory Agents; D005338:Fibrin Fibrinogen Degradation Products; D005343:Fibrinolytic Agents; D015850:Interleukin-6; C036309:fibrin fragment D